MALAISE is the #11 most commonly reported adverse reaction for SILDENAFIL CITRATE, manufactured by Viatris Specialty LLC. There are 4,424 FDA adverse event reports linking SILDENAFIL CITRATE to MALAISE. This represents approximately 1.8% of all 242,442 adverse event reports for this drug.
SILDENAFIL CITRATE has an overall safety score of 85 out of 100. Patients taking SILDENAFIL CITRATE who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
MALAISE4,424 of 242,442 reports
MALAISE is a less commonly reported adverse event for SILDENAFIL CITRATE, but still significant enough to appear in the safety profile.
Other Side Effects of SILDENAFIL CITRATE
In addition to malaise, the following adverse reactions have been reported for SILDENAFIL CITRATE:
MALAISE has been reported as an adverse event in 4,424 FDA reports for SILDENAFIL CITRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is MALAISE with SILDENAFIL CITRATE?
MALAISE accounts for approximately 1.8% of all adverse event reports for SILDENAFIL CITRATE, making it a notable side effect.
What should I do if I experience MALAISE while taking SILDENAFIL CITRATE?
If you experience malaise while taking SILDENAFIL CITRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.